Literature DB >> 17272809

Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties.

Xiongwen Chen1, Rachel M Wilson, Hajime Kubo, Remus M Berretta, David M Harris, Xiaoying Zhang, Naser Jaleel, Scott M MacDonnell, Claudia Bearzi, Jochen Tillmanns, Irina Trofimova, Toru Hosoda, Federico Mosna, Leanne Cribbs, Annarosa Leri, Jan Kajstura, Piero Anversa, Steven R Houser.   

Abstract

Recent studies suggest that rather than being terminally differentiated, the adult heart is a self-renewing organ with the capacity to generate new myocytes from cardiac stem/progenitor cells (CS/PCs). This study examined the hypotheses that new myocytes are generated during adolescent growth, to increase myocyte number, and these newly formed myocytes are initially small, mononucleated, proliferation competent, and have immature properties. Ventricular myocytes (VMs) and cKit(+) (stem cell receptor) CS/PCs were isolated from 11- and 22-week feline hearts. Bromodeoxyuridine incorporation (in vivo) and p16(INK4a) immunostaining were measured to assess myocyte cell cycle activity and senescence, respectively. Telomerase activity, contractions, Ca(2+) transients, and electrophysiology were compared in small mononucleated (SMMs) and large binucleated (LBMs) myocytes. Heart mass increased by 101% during adolescent growth, but left ventricular myocyte volume only increased by 77%. Most VMs were binucleated (87% versus 12% mononucleated) and larger than mononucleated myocytes. A greater percentage of SMMs was bromodeoxyuridine positive (SMMs versus LBMs: 3.1% versus 0.8%; P<0.05), and p16(INK4a) negative and small myocytes had greater telomerase activity than large myocytes. Contractions and Ca(2+) transients were prolonged in SMMs versus LBMs and Ca(2+) release was disorganized in SMMs with reduced transient outward current and T-tubule density. The T-type Ca(2+) current, usually seen in fetal/neonatal VMs, was found exclusively in SMMs and in myocytes derived from CS/PC. Myocyte number increases during adolescent cardiac growth. These new myocytes are initially small and functionally immature, with patterns of ion channel expression normally found in the fetal/neonatal period.

Entities:  

Mesh:

Year:  2007        PMID: 17272809     DOI: 10.1161/01.RES.0000259560.39234.99

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  52 in total

Review 1.  The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.

Authors:  Brian Wadugu; Bernhard Kühn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 2.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 3.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

4.  Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells.

Authors:  Qiang Xiong; Lei Ye; Pengyuan Zhang; Michael Lepley; Cory Swingen; Liying Zhang; Dan S Kaufman; Jianyi Zhang
Journal:  Circ Res       Date:  2012-06-21       Impact factor: 17.367

Review 5.  Adhesion proteins, stem cells, and arrhythmogenesis.

Authors:  Nikki Gillum; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2008-01-05       Impact factor: 3.231

Review 6.  Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies.

Authors:  Rachel Ruckdeschel Smith; Lucio Barile; Elisa Messina; Eduardo Marbán
Journal:  Heart Rhythm       Date:  2008-02-15       Impact factor: 6.343

Review 7.  Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis.

Authors:  Maria Grazia Perino; Satoshi Yamanaka; Jinliang Li; Anna M Wobus; Kenneth R Boheler
Journal:  J Mol Cell Cardiol       Date:  2008-05-11       Impact factor: 5.000

8.  Imatinib activates pathological hypertrophy by altering myocyte calcium regulation.

Authors:  Larry A Barr; Catherine A Makarewich; Remus M Berretta; Hui Gao; Constantine D Troupes; Felix Woitek; Fabio Recchia; Hajime Kubo; Thomas Force; Steven R Houser
Journal:  Clin Transl Sci       Date:  2014-06-16       Impact factor: 4.689

9.  Persistent increases in Ca(2+) influx through Cav1.2 shortens action potential and causes Ca(2+) overload-induced afterdepolarizations and arrhythmias.

Authors:  Xiaoying Zhang; Xiaojie Ai; Hiroyuki Nakayama; Biyi Chen; David M Harris; Mingxin Tang; Yuping Xie; Christopher Szeto; Yingxin Li; Ying Li; Hongyu Zhang; Andrea D Eckhart; Walter J Koch; Jeffery D Molkentin; Xiongwen Chen
Journal:  Basic Res Cardiol       Date:  2015-11-26       Impact factor: 17.165

10.  Do binucleate cardiomyocytes have a role in myocardial repair? Insights using isolated rodent myocytes and cell culture.

Authors:  Michael J Stephen; Brian J Poindexter; Johan A Moolman; David Sheikh-Hamad; Roger J Bick
Journal:  Open Cardiovasc Med J       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.